Free Trial

Chemed (CHE) Competitors

$543.66
-0.51 (-0.09%)
(As of 06/7/2024 ET)

CHE vs. LH, DGX, DVA, RCM, CRVL, AMED, AMN, MD, CCRN, and OPCH

Should you be buying Chemed stock or one of its competitors? The main competitors of Chemed include Laboratory Co. of America (LH), Quest Diagnostics (DGX), DaVita (DVA), R1 RCM (RCM), CorVel (CRVL), Amedisys (AMED), AMN Healthcare Services (AMN), Pediatrix Medical Group (MD), Cross Country Healthcare (CCRN), and Option Care Health (OPCH).

Chemed vs.

Laboratory Co. of America (NYSE:LH) and Chemed (NYSE:CHE) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, valuation, media sentiment, analyst recommendations, earnings, institutional ownership, community ranking and profitability.

Laboratory Co. of America has higher revenue and earnings than Chemed. Chemed is trading at a lower price-to-earnings ratio than Laboratory Co. of America, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Laboratory Co. of America$12.16B1.36$418M$4.9739.56
Chemed$2.26B3.63$272.51M$18.5829.26

Laboratory Co. of America presently has a consensus price target of $241.86, suggesting a potential upside of 23.02%. Chemed has a consensus price target of $673.50, suggesting a potential upside of 23.88%. Given Laboratory Co. of America's stronger consensus rating and higher probable upside, analysts clearly believe Chemed is more favorable than Laboratory Co. of America.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Laboratory Co. of America
0 Sell rating(s)
3 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.79
Chemed
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Chemed has a net margin of 12.36% compared to Chemed's net margin of 3.52%. Laboratory Co. of America's return on equity of 30.52% beat Chemed's return on equity.

Company Net Margins Return on Equity Return on Assets
Laboratory Co. of America3.52% 14.68% 7.03%
Chemed 12.36%30.52%20.13%

95.9% of Laboratory Co. of America shares are held by institutional investors. Comparatively, 95.9% of Chemed shares are held by institutional investors. 0.9% of Laboratory Co. of America shares are held by company insiders. Comparatively, 3.3% of Chemed shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Laboratory Co. of America has a beta of 1.04, suggesting that its stock price is 4% more volatile than the S&P 500. Comparatively, Chemed has a beta of 0.46, suggesting that its stock price is 54% less volatile than the S&P 500.

Laboratory Co. of America pays an annual dividend of $2.88 per share and has a dividend yield of 1.5%. Chemed pays an annual dividend of $1.60 per share and has a dividend yield of 0.3%. Laboratory Co. of America pays out 57.9% of its earnings in the form of a dividend. Chemed pays out 8.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Laboratory Co. of America has increased its dividend for 1 consecutive years. Laboratory Co. of America is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

In the previous week, Laboratory Co. of America had 2 more articles in the media than Chemed. MarketBeat recorded 11 mentions for Laboratory Co. of America and 9 mentions for Chemed. Laboratory Co. of America's average media sentiment score of 1.11 beat Chemed's score of 0.80 indicating that Chemed is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Laboratory Co. of America
5 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Chemed
6 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Laboratory Co. of America received 272 more outperform votes than Chemed when rated by MarketBeat users. Likewise, 64.11% of users gave Laboratory Co. of America an outperform vote while only 63.46% of users gave Chemed an outperform vote.

CompanyUnderperformOutperform
Laboratory Co. of AmericaOutperform Votes
602
64.11%
Underperform Votes
337
35.89%
ChemedOutperform Votes
330
63.46%
Underperform Votes
190
36.54%

Summary

Laboratory Co. of America beats Chemed on 11 of the 21 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CHE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CHE vs. The Competition

MetricChemedHome health care services IndustryMedical SectorNYSE Exchange
Market Cap$8.23B$2.81B$5.25B$17.92B
Dividend Yield0.29%0.29%2.76%3.57%
P/E Ratio29.2612.81112.3823.15
Price / Sales3.631.162,437.6214.27
Price / Cash22.1313.9535.2819.35
Price / Book7.393.034.974.99
Net Income$272.51M-$57.02M$110.78M$975.94M
7 Day Performance-1.93%0.91%-1.09%-1.87%
1 Month Performance-5.31%3.04%-0.96%-1.65%
1 Year Performance1.95%12.89%4.05%9.19%

Chemed Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LH
Laboratory Co. of America
4.8855 of 5 stars
$195.01
+0.1%
$241.86
+24.0%
-11.0%$16.44B$12.16B39.2467,000Analyst Downgrade
DGX
Quest Diagnostics
4.6958 of 5 stars
$141.10
-0.6%
$146.67
+3.9%
+4.9%$15.67B$9.25B18.9948,000Analyst Downgrade
Positive News
DVA
DaVita
3.2418 of 5 stars
$145.61
-1.0%
$144.67
-0.6%
+43.1%$12.90B$12.34B16.5570,000Analyst Downgrade
Positive News
RCM
R1 RCM
4.5141 of 5 stars
$12.79
-0.5%
$16.31
+27.5%
-23.5%$5.39B$2.25B-159.8830,000Positive News
CRVL
CorVel
0.34 of 5 stars
$239.85
flat
N/A+15.0%$4.11B$795.31M54.514,870Analyst Downgrade
AMED
Amedisys
2.8386 of 5 stars
$91.97
+0.9%
$100.80
+9.6%
-0.9%$3.01B$2.24B-143.7019,000News Coverage
Positive News
AMN
AMN Healthcare Services
4.7996 of 5 stars
$55.46
-0.9%
$75.57
+36.3%
-49.4%$2.11B$3.79B14.913,585
MD
Pediatrix Medical Group
2.0737 of 5 stars
$7.42
+1.5%
$9.38
+26.3%
-50.1%$624.39M$1.99B-8.735,170Analyst Upgrade
Analyst Revision
News Coverage
Gap Up
High Trading Volume
CCRN
Cross Country Healthcare
4.6126 of 5 stars
$14.70
-2.8%
$20.83
+41.7%
-47.3%$511.12M$2.02B11.3110,831
OPCH
Option Care Health
4.7271 of 5 stars
$29.87
+0.2%
$40.00
+33.9%
-6.9%$5.19B$4.43B19.657,802News Coverage
Positive News

Related Companies and Tools

This page (NYSE:CHE) was last updated on 6/9/2024 by MarketBeat.com Staff

From Our Partners